SWOT Analysis for Bafna Pharmaceuticals Ltd.

Add SWOT widget to your site/app

Positive Breakout Third Resistance ( LTP > R3)
High DVM Mid and Small Caps (subscription)
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Stocks whose current price is 20% higher than week low, and more than previous close
Weekly Strategy: High Momentum Score Stocks (subscription)
Higher DVM Stocks Among Midcaps and Largecaps
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with rising net profit margins - quarterly as well as TTM basis
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing profits every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
RSI indicating price strength
High Volume, High Gain
Top Gainers
High Volume, High Gain
New 52 Week High
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Positive Breakout Third Resistance ( LTP > R3)

High DVM Mid and Small Caps (subscription)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Stocks whose current price is 20% higher than week low, and more than previous close

Weekly Strategy: High Momentum Score Stocks (subscription)

Higher DVM Stocks Among Midcaps and Largecaps

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with rising net profit margins - quarterly as well as TTM basis

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock gained more than 20% in one month

RSI indicating price strength

High Volume, High Gain

Top Gainers

High Volume, High Gain

New 52 Week High

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Annual net profit declining for last 2 years

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Annual net profit declining for last 2 years

FII / FPI or Institutions increasing their shareholding

FII / FPI or Institutions increasing their shareholding

Stocks with improving cash flow, with good durability
Strong Performers - High DVM Stocks
Rising Delivery Percentage Compared to Prev Day
Dragonfly Doji (Bullish Reversal)
Trendlynes high return technically strong value stocks (subscription)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Decline in Quarterly Net Profit with falling Profit Margin (YoY)

Stocks with improving cash flow, with good durability

Strong Performers - High DVM Stocks

Rising Delivery Percentage Compared to Prev Day

Dragonfly Doji (Bullish Reversal)

Trendlynes high return technically strong value stocks (subscription)

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)

Bafna Pharmaceuticals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Bafna Pharmaceuticals Ltd. has 32 Strengths, 4 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential